SMTL ID : 6i99.2 (1 other biounit)

Bone Marrow Tyrosine Kinase in Chromosome X in complex with a newly designed covalent inhibitor JS24

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x H88: ~{N}-[2-methyl-5-[8-[4-(methylsulfonylamino)phenyl]-2-oxidanylidene-benzo[h][1,6]naphthyridin-1-yl]phenyl]-3-oxidanyl-propanamide(Covalent)

H88.1: 21 residues within 4Å: Chain A: L.26, G.27, S.28, G.29, V.34, A.46, K.48, V.76, T.92, E.93, Y.94, I.95, S.96, N.97, G.98, C.99, L.101, N.102, R.143, L.146, S.156 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.34, A:A.46, A:Y.94, A:L.146, A:L.146 Hydrogen bonds: A:K.48, A:I.95, A:N.102, A:R.143 Water bridges: A:C.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Seixas, J.D. et al., Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors. Chem.Biol. (2020)

Release Date

2020-05-27

Peptides

Cytoplasmic tyrosine-protein kinase BMX: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Cytoplasmic tyrosine-protein kinase BMX

Related Entries With Identical Sequence